Ambev S.A. (ABEV)
| Market Cap | 43.18B +8.3% |
| Revenue (ttm) | 17.18B -1.6% |
| Net Income | 3.04B -1.8% |
| EPS | 0.18 -1.0% |
| Shares Out | 15.42B |
| PE Ratio | 15.49 |
| Forward PE | 14.34 |
| Dividend | $0.12 (4.44%) |
| Ex-Dividend Date | Sep 23, 2026 |
| Volume | 13,013,464 |
| Open | 2.750 |
| Previous Close | 2.730 |
| Day's Range | 2.735 - 2.780 |
| 52-Week Range | 2.280 - 3.450 |
| Beta | 0.22 |
| Analysts | Hold |
| Price Target | 3.19 (+15.44%) |
| Earnings Date | Oct 29, 2026 |
About ABEV
Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, soft drinks, malt and food, and other beverages in Brazil, Central America and Caribbean, Latin America South, and Canada. The company offers beer, ready-to-drink cocktails and spritzers, soft drinks, water, teas, and isotonic drinks under the Brahma, Skol, Antarctica, Original, Quilmes, Andes Origen, Patricia, Paceha, Huari, Pilsen, Presidente, Balboa, Guaraná Antarctica, and Beats brands. It sells its products to distributors, supermar... [Read more]
Financial Performance
In 2025, Ambev's revenue was 88.24 billion, a decrease of -1.35% compared to the previous year's 89.45 billion. Earnings were 15.50 billion, an increase of 7.38%.
Financial numbers in BRL Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for ABEV stock is "Hold." The 12-month stock price target is $3.19, which is an increase of 15.44% from the latest price.
News
Ambev price target lowered to $3 from $3.50 at Barclays
Barclays lowered the firm’s price target on Ambev (ABEV) to $3 from $3.50 and keeps an Equal Weight rating on the shares.
Ambev Q3 Earnings Call Highlights
Ambev NYSE: ABEV reported third-quarter growth in volume, revenue, profitability and normalized earnings, as the brewer cited portfolio gains, commercial execution and cost discipline across its marke...
Ambev (ABEV) Q3 2026 Earnings Call Transcript
Brand equity hits five-year record as organic revenue grows 7.6% and margins expand.
Ambev Earnings Call Transcript: Q3 2026
Q3 revenue rose 7.6% and normalized EBITDA 8.9%, with 40 bps of margin expansion; normalized EPS grew 15.4%. Strong cash generation and broad share gains supported continued growth investment and shareholder returns.
Ambev Earnings release: Q3 2026
Ambev released its Q3 2026 earnings on October 29, 2026, summarizing the period's financial results.
Ambev Quarterly report: Q3 2026
Ambev has published its Q3 2026 quarterly earnings report on October 29, 2026.
Ambev Slides: Q3 2026
Ambev has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 29, 2026.
Ambev S.A. Board Approves Share Buyback Program of Up to 190,000,000 Common Shares
Ambev S.A. announced that its Board of Directors has approved a share buyback program for the repurchase of shares issued by the Company up to the limit of 190,000,000 common shares. The program, whic...
Ambev S.A. Reports 3Q26 Results and Approves 190,000,000 Share Buyback Program
Ambev S.A. reported its third quarter 2026 results, with organic total volume increasing by 0.8% and organic net revenue growing by 7.6% compared to the prior year. Consolidated volumes were driven by...
Why Ambev S.A. Dropped Today
Ambev stock plunged after the surprise win for the leftist Lula da Silva in Brazil over the weekend.
3 Reasons Why Growth Investors Shouldn't Overlook Ambev (ABEV)
Ambev (ABEV) possesses solid growth attributes, which could help it handily outperform the market.
XP and AmBev Stocks Slump. Brazil's Path Is Unworkable After Shock Election Win.
Shares of Brazilian companies plummet after leftist President Lula's surprise victory in Sunday's runoff election.
SpaceX, CoreWeave, Ambev, XP, Exxon, and More Stocks That Explain Today's Market
SpaceX rises but neocloud stocks slide after Elon Musk says they face “guppy-level death and consolidation.”
Is Ambev (ABEV) a Solid Growth Stock? 3 Reasons to Think "Yes"
Ambev (ABEV) could produce exceptional returns because of its solid growth attributes.
Ambev downgraded to Underperform from Neutral at BofA
BofA downgraded Ambev (ABEV) to Underperform from Neutral with an unchanged price target of $3.30. The stock went up by 3% since the first round of Brazil’s presidential election, reflecting…
Ambev price target lowered to $2.85 from $2.90 at UBS
UBS lowered the firm’s price target on Ambev (ABEV) to $2.85 from $2.90 and keeps a Sell rating on the shares.
Ambev (ABEV) Q2 2026 Earnings Call Transcript
Premium beer surged 20% as World Cup activation drove margin expansion.
Ambev Q2 Earnings Call Highlights
Ambev NYSE: ABEV reported stronger second-quarter operating performance, led by beer-volume growth, revenue management and margin expansion, while continuing to invest in brand activations tied to the...
Ambev Earnings Call Transcript: Q2 2026
Second quarter and first half results showed strong volume, revenue, and EBITDA growth, with margin expansion and robust cash flow. Premiumization, digital ecosystem gains, and disciplined capital allocation supported broad-based performance across markets, despite weather and macro headwinds.
Ambev Earnings release: Q2 2026
Ambev released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Ambev Quarterly report: Q2 2026
Ambev has published its Q2 2026 quarterly earnings report on July 30, 2026.
Ambev Slides: Q2 2026
Ambev has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Scotiabank downgrades Ambev on valuation, tougher compares
Scotiabank downgraded Ambev (ABEV) to Sector Perform from Outperform with an unchanged price target of R$16. The company’s positives are fully priced into the shares and the upside is now…
Ambev downgraded to Sector Perform from Outperform at Scotiabank
Scotiabank downgraded Ambev (ABEV) to Sector Perform from Outperform with a R$16 price target
Ambev upgraded to Buy from Neutral at BTG Pactual
BTG Pactual upgraded Ambev (ABEV) to Buy from Neutral with a R$20 price target